Dyne Therapeutics : ACHIEVE & DELIVER Clinical Update Presentation
Achieving the Promise of F O R C E to Deliver for Patients F O R C E ...
Source: marketscreener.com
📰 Forward Looking Statements News
Page 12 - Forward Looking Statements News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Forward Looking Statements. Real-time updates on events, politics, business and more.
Regency Centers : May 2024 Investor Presentation
Investor Presentation May 2024 Glenwood Green | Old Bridge, NJ ...
United States Urstadt Biddle Shopping Centers Exchange Commission Company Acquisition Of Urstadt Biddle Health Crises
Source: marketscreener.com
Onward Medical N : – Company Presentation (May 2024)
Company Deck May 2024 Forward Looking Statements This Presentation may include statements,...
Source: marketscreener.com
Dupixent® (dupilumab) Late-Breaking Data from NOTUS Confirmatory Phase 3 COPD Trial Presented at ATS and Published in The New England Journal of Medicine
NOTUS results confirm landmark data from the Phase 3 BOREAS trial and show Dupixent significantly reduced exacerbations by 34% and improved lung function, compared to placebo, in uncontrolled chronic...
Source: marketscreener.com
Dupixent® (dupilumab) Late-Breaking Data from NOTUS
NOTUS results confirm landmark data from the Phase 3 BOREAS trial and show Dupixent significantly reduced exacerbations by 34% and improved lung function,...
United States France General Regeneron Velocimmune Surya Bhatt Georged Yancopoulos American Thoracic Society
Source: globenewswire.com
Sanofi: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM
Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM NOTUS results confirm landmark data from the phase 3 BOREAS study and show Dupixent significantly
Source: finanznachrichten.de
Northwest Natural : May 2024 - MarketScreener
Investor Presentation May 2024 Investor Information ...
United States Nw Natural Holdings Forward Looking Statements Securities Litigation Reform Act Financial Condition Qualitative Disclosure
Source: marketscreener.com
OptiNose, Inc. (NASDAQ:OPTN) Q1 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the OptiNoses Q1 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Source: insidermonkey.com
Chesapeake Utilities : 2024 AGA Financial Forum Presentation
AGA Financial Forum MAY 19 - 21, 2024 Safe Harbor for Forward-Looking Statements ...
Safe Harbor Forward Looking Statements Private Securities Litigation Reform Act Chesapeake Utilities Annual Report Adjusted Gross Margin Adjusted Net Income
Source: marketscreener.com